• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从替代方法中吸取的教训及其在 21 世纪新毒理学中的验证。

Lessons learned from alternative methods and their validation for a new toxicology in the 21st century.

机构信息

Environmental Health Sciences, Center for Alternatives to Animal Testing, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 21205, USA.

出版信息

J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):277-90. doi: 10.1080/10937404.2010.483945.

DOI:10.1080/10937404.2010.483945
PMID:20574902
Abstract

Europe and the United States further the development of new toxicological tools in different ways. While the replacement of animal tests has been promoted strongly in Europe over the last decades (following the 3Rs principles--reduce, replace, refine), in the United States the vision for a toxicology in the 21st century (Tox-21c), which was prompted by the National Research Council document only 3 years ago, dominates the discussion. In both cases, there is significant political support. However, while in Europe the horizontal animal welfare legislation from 1986 (which urges the use of 3Rs methods wherever possible) currently under revision and cosmetics and chemical legislation are the primary drivers, in the United States it is mainly federal agencies, most prominently the U.S. Environmental Protection Agency (EPA), that made the implementation of the NRC report their toxicity testing strategy only in 2009. This preempts such likely legislative measures as the reauthorization of the Toxic Substances Control Act (TSCA) in the United States. The European implementation is characterized by substantial broad funding programs to develop 3Rs methods and can be termed a "bottom-up" approach; in contrast, the Tox-21 program represents a "top-down" approach, where programmed research is carried out and commissioned. It is postulated that the two approaches are two sides of the same coin, and instruct and complement each other. However, more importantly, if brought together they can result in a Human Toxicology Project and a real revolution in regulatory toxicology.

摘要

欧洲和美国以不同的方式推动新毒理学工具的发展。在过去几十年中,欧洲一直在大力推动动物试验的替代(遵循 3R 原则——减少、替代、优化),而在美国,21 世纪毒理学的愿景(Tox-21c)主导着讨论,这一愿景是由美国国家研究委员会在仅仅 3 年前的一份文件所引发的。在这两种情况下,都有重大的政治支持。然而,在欧洲,1986 年出台的横向动物福利立法(敦促尽可能使用 3R 方法)正在修订之中,化妆品和化学立法是主要的推动力;而在美国,主要是联邦机构,尤其是美国环境保护署(EPA),在 2009 年才将 NRC 报告的实施作为其毒性测试策略。这先于美国《有毒物质控制法》(TSCA)的重新授权等可能的立法措施。欧洲的实施特点是有大量广泛的资金计划来开发 3R 方法,可以称之为“自下而上”的方法;相比之下,Tox-21 计划代表了一种“自上而下”的方法,其中进行和委托了有计划的研究。有人假设,这两种方法是同一枚硬币的两面,相互指导和补充。然而,更重要的是,如果将它们结合起来,它们可以促成一个人类毒理学计划和监管毒理学的真正革命。

相似文献

1
Lessons learned from alternative methods and their validation for a new toxicology in the 21st century.从替代方法中吸取的教训及其在 21 世纪新毒理学中的验证。
J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):277-90. doi: 10.1080/10937404.2010.483945.
2
Implementing the National Academy's Vision and Strategy for Toxicity Testing: opportunities and challenges under the U.S. Toxic Substances Control Act.实施国家科学院毒性测试的愿景和战略:美国有毒物质控制法案下的机遇和挑战。
J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):376-84. doi: 10.1080/10937404.2010.483952.
3
An animal protection perspective on 21st century toxicology.从动物保护角度看 21 世纪毒理学
J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):291-8. doi: 10.1080/10937404.2010.483946.
4
Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).实验动物安全研究的替代方法:在新的欧洲化学品法规(REACH)下化学品风险评估中的作用。
Arch Toxicol. 2008 Apr;82(4):211-36. doi: 10.1007/s00204-008-0279-9. Epub 2008 Mar 6.
5
From alternative methods to a new toxicology.从替代方法到新毒理学。
Eur J Pharm Biopharm. 2011 Apr;77(3):338-49. doi: 10.1016/j.ejpb.2010.12.027. Epub 2010 Dec 30.
6
The future of toxicity testing.毒性测试的未来。
J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):163-96. doi: 10.1080/10937404.2010.483933.
7
Toxicology in the 21st century--working our way towards a visionary reality.21 世纪毒理学——朝着富有远见的现实迈进。
Toxicol In Vitro. 2011 Jun;25(4):874-81. doi: 10.1016/j.tiv.2011.02.008. Epub 2011 Feb 19.
8
Toxicity testing in the 21st century: how will it affect risk assessment?21 世纪的毒性测试:将如何影响风险评估?
J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):361-75. doi: 10.1080/10937404.2010.483951.
9
Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.论“21 世纪的毒性测试:愿景与策略”。
Hum Exp Toxicol. 2010 Jan;29(1):15-9. doi: 10.1177/0960327109354657.
10
Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.21 世纪的毒性测试:愿景与策略述评。
Hum Exp Toxicol. 2010 Jan;29(1):11-4. doi: 10.1177/0960327109354660.

引用本文的文献

1
Assessing Bioconcentration and Biotransformation of BDE-47 In Vitro: The Relevance of Bioavailable and Intracellular Concentrations.体外评估BDE - 47的生物富集和生物转化:生物可利用浓度和细胞内浓度的相关性
J Xenobiot. 2025 Jun 16;15(3):93. doi: 10.3390/jox15030093.
2
MolBook UNIPI─Create, Manage, Analyze, and Share Your Chemical Data for Free.莫尔本 UNIPI─免费创建、管理、分析和共享您的化学数据。
J Chem Inf Model. 2023 Jul 10;63(13):3977-3982. doi: 10.1021/acs.jcim.3c00278. Epub 2023 Jun 26.
3
IVIVE: Facilitating the Use of Toxicity Data in Risk Assessment and Decision Making.
体外体内外推法:助力毒性数据在风险评估与决策制定中的应用
Toxics. 2022 May 1;10(5):232. doi: 10.3390/toxics10050232.
4
Development of the SciRAP Approach for Evaluating the Reliability and Relevance of Toxicity Data.用于评估毒性数据可靠性和相关性的SciRAP方法的开发。
Front Toxicol. 2021 Oct 15;3:746430. doi: 10.3389/ftox.2021.746430. eCollection 2021.
5
Development, scrutiny, and modulation of transient reporter gene assays of the xenobiotic metabolism pathway in zebrafish hepatocytes.斑马鱼肝细胞中外源物质代谢途径瞬态报告基因检测方法的建立、检验和调控。
Cell Biol Toxicol. 2023 Jun;39(3):991-1013. doi: 10.1007/s10565-021-09659-0. Epub 2021 Oct 15.
6
Biologia futura: animal testing in drug development-the past, the present and the future.未来生物学:药物研发中的动物试验——过去、现在和未来。
Biol Futur. 2020 Dec;71(4):443-452. doi: 10.1007/s42977-020-00050-4. Epub 2020 Oct 21.
7
Modeling Bioavailable Concentrations in Zebrafish Cell Lines and Embryos Increases the Correlation of Toxicity Potencies across Test Systems.建立斑马鱼细胞系和胚胎的生物有效浓度模型可提高不同测试系统间毒性效力的相关性。
Environ Sci Technol. 2021 Jan 5;55(1):447-457. doi: 10.1021/acs.est.0c04872. Epub 2020 Dec 15.
8
Comparing the preclinical risk profile of inhalable candidate and potential candidate modified risk tobacco products: A bridging use case.比较可吸入候选和潜在候选的改良风险烟草产品的临床前风险概况:一个过渡用例。
Toxicol Rep. 2020 Sep 12;7:1187-1206. doi: 10.1016/j.toxrep.2020.09.004. eCollection 2020.
9
Engineered Nanomaterials and Type I Allergic Hypersensitivity Reactions.工程纳米材料与 I 型过敏性超敏反应。
Front Immunol. 2020 Feb 14;11:222. doi: 10.3389/fimmu.2020.00222. eCollection 2020.
10
Perspectives on to Extrapolations.关于外推法的观点。 (你提供的原文“Perspectives on to Extrapolations.”表述似乎不太完整准确,我按照字面意思尽量贴近翻译了,你可以检查下原文是否准确。)
Appl In Vitro Toxicol. 2018 Dec 1;4(4):305-316. doi: 10.1089/aivt.2016.0026. Epub 2018 Dec 8.